SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000919574-19-000328
Filing Date
2019-01-11
Accepted
2019-01-11 12:44:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8121757_13da.htm SC 13D/A 55625
  Complete submission text file 0000919574-19-000328.txt   57203
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Subject) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: SC 13D/A | Act: 34 | File No.: 005-88759 | Film No.: 19521930
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 15 DAVIES STREET LONDON X0 W1K 3AG
Business Address 15 DAVIES STREET LONDON X0 W1K 3AG 44 20 7290 5500
LANSDOWNE PARTNERS (UK) LLP (Filed by) CIK: 0001608485 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A